Apollo Hospitals Enterprise Limited (APOLLOHOSP) — Financial Results | 10 February 2026(3 announcements)

Apollo Hospitals reported consolidated Q3 FY2025-26 revenue of ₹6,477 crores (17% YoY growth) with profit after tax of ₹502 crores (35% YoY growth) and EBITDA of ₹965 crores (27% YoY growth). Nine-month revenue reached ₹18,623 crores (15% YoY growth) with PAT of ₹1,451 crores (33% YoY growth). The company declared an interim dividend of ₹10 per share (200% of face value). Healthcare Services segment grew 14%, while diagnostics and digital/pharmacy platforms each expanded 20%.

Apollo Hospitals reported Q3 FY26 consolidated revenue of ₹64,774 million, growing 17% YoY, with EBITDA of ₹9,653 million (up 27% YoY) and PAT of ₹5,023 million (up 35% YoY). The healthcare services segment drove growth with 14% revenue increase. Nine-month performance showed ₹186,230 million revenue (up 15% YoY) and ₹14,123 million PAT (up 34% YoY). The company operates 76 hospitals with 67% occupancy and expanded digital health GMV to ₹525 crore (up 28% YoY). Diagnostics and digital segments each grew 20% YoY.

Apollo Hospitals reported Q3 FY26 consolidated revenue of ₹64,774 million, up 17% YoY, with EBITDA of ₹9,653 million (growth 27% YoY) and net profit of ₹5,023 million (growth 35% YoY). Healthcare Services segment grew 14% driven by 4% volume growth and 11% higher average revenue per inpatient. The company is executing a ₹8,200 crore expansion plan adding 4,444 beds across five years. Diagnostics grew 38% YoY in 9M FY26. Platform GMV reached ₹525 crore, up 28% YoY.